Latest filing published 10 Jan 2019 for IDL BIOTECH AB, €342k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Max Pihlqvist: trading record in brief
Max Pihlqvist discloses dealings in IDL Biotech AB to Finansinspektionen. We count 4 filings; the first trade dates from 27 November 2018 and the latest from 10 January 2019.
The open-market side counts 2 purchases for €1.5M alongside 1 sale for €1.5M. Purchases outweigh sales by €7,408. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Most recently, on 10 January 2019, the filings show a transaction worth €342k in IDL Biotech AB. The most recent open-market purchase was published on 9 December 2018, 2,890 days ago. Typically, a trade is published a median of 2 days after it takes place. The regulation allows three business days to notify a trade (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Max Pihlqvist
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,916,666 shares@ SEK 1.2018.9% of flowAktieISIN SE0000514747FI:csv-11138c556480f083bc05
- 5,500,000 shares@ SEK 2.7080.7% of flowAktieISIN SE0000514747FI:csv-4e1b6e2f5f07cb47b3a9
- 63,600 shares@ SEK 1.200.4% of flowBTA (betald tecknad aktie)ISIN SE0011896356FI:csv-a5a4d5adb1ad2fb0eaeeCanonical exit: 25 Feb 2019 (T+90)
3 of 3 declarations